
058495: Measles, Mumps, Rubella (MMR) Immunity Profile
Measles IgG antibodies; Mumps IgG antibodies; Rubella IgG antibodies. This test is used to aid in the determination of serological status to measles, mumps, and rubella viruses. A positive result generally indicates exposure to virus or previous vaccination. A positive result is considered adequate laboratory evidence of immunity.
VENTANA MMR RxDx Panel (US FDA Approved) - Roche …
The VENTANA MMR RxDx Panel is the first and only IHC-based assay approved to identify solid tumor patients eligible for treatment with JEMPERLI (dostarlimab-gxly) or KEYTRUDA (pembrolizumab).
Measles, Mumps, and Rubella (MMR) Antibodies (IgG) Panel, Immune Status ...
Measles, Mumps, and Rubella (MMR) Antibodies (IgG) Panel, Immune Status - This panel provides presumptive evidence of immunity to measles, mumps, and rubella for purposes of routine vaccination, for students at post-high school educational institutions, and for …
The VENTANA MMR IHC Panel is indicated in patients diagnosed with colorectal cancer (CRC) to detect mismatch repair (MMR) proteins deficiency as an aid in the identification of probable Lynch syndrome and to detect BRAF V600E protein as an aid to differentiate between sporadic CRC and probable Lynch syndrome.
Occupation Screen - MMR/VZV Antibody Assessment Panel, IgG
2024年10月7日 · Use only to provide evidence of vaccination or prior infection by measles, mumps, rubella and varicella-zoster viruses. Indicates whether a test has been approved by the New York State Department of Health. This test is New York state approved. Patient Preparation Instructions patient must follow before/during specimen collection.
zzIO-234: MMR Panel by IHC - Labcorp
MSI testing can detect an abnormal number of microsatellite repeats, which indicates a defective mismatch repair (MMR) gene. A result of microsatellite instability-high (MSI-H) means that a high number of microsatellite repeats were found. IHC testing can detect the presence or absence of the protein products of the MMR genes.
VENTANA MMR RxDx Panel – P200019 - FDA
VENTANA MMR RxDx Panel is a laboratory test designed to detect mismatch repair (MMR) proteins (MSH6, PMS2, MSH2 and MLH1) in patients diagnosed with endometrial cancer. If the MMR...
MMR (IgG) Panel (Measles, Mumps, Rubella) Titers
The MMR (IgG) Panel (Measles, Mumps, Rubella) Titers test contains 1 test with 3 biomarkers . Brief Description: The MMR Titer test is a blood test that measures the levels of immunoglobulin G (IgG) antibodies specific to the Measles, Mumps, and Rubella (MMR) viruses. It provides a comprehensive assessment of an individual's immune response to ...
VariantPro错配修复(MMR)基因检测Panel介绍_步式 - 搜狐
2019年4月29日 · MMR Panel基于VariantPro™ 一步法靶向文库制备技术,按99.47%扩增覆盖MLH1、MSH2、MSH6,PMS2 4个基因全部编码区设计,以最少的人工操作,准确鉴定与分析基因编码区上所有突变信息,为临床提供精准的分子辅助诊疗手段。
VENTANA MMR RxDx IHC Panel - Roche Diagnostics USA
VENTANA MMR RxDx Panel is a qualitative immunohistochemistry test intended for use in the assessment of mismatch repair (MMR) proteins (MLH1, PMS2, MSH2 and MSH6) in formalin-fixed, paraffin-embedded (FFPE) tissues by light microscopy.